Israel has signed a memorandum of understanding to perform clinical trials of its homegrown vaccine in Georgia and Ukraine.
The Israel Institute for Biological Research (IIBR), run by the Defense Ministry, has signed a memorandum of understanding with NRx Pharmaceuticals to complete the clinical trials of its homegrown COVID-19 vaccine, according to a statement.
The vaccine, known as Brilife, is in third-stage clinical trials, and will be tested on tens of thousands of volunteers in Georgia, Ukraine and Israel, the statement said.
“I anticipate that with this agreement, we will be able to complete the development of the vaccine and enable Israel to produce vaccines independently, because as we have seen recently – the coronavirus is not going anywhere,” said Defense Minister Benny Gantz.
In February, Pfizer CEO referred to Israel as his company's vaccine "lab."
The All Israel News Staff is a team of journalists in Israel.